Position in JNJ
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$10,636,771
+$490,067 QoQ
Shares Held
41,882
+0.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.94%
of 13F equity value
Holder Rank
#1,075
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Princeton Global Asset Management LLC holds $25,670,962 across 14 Drug Manufacturers - General names. JNJ ranks #1 (41.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
41,882 | $10,636,771 | |
| 2 | LLY |
ELI LILLY & Co
|
5,815 | $6,974,686 | |
| 3 | ABBV |
AbbVie Inc.
|
26,493 | $6,666,698 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,825 | $491,512 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,594 | $201,385 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,450 | $198,789 | |
| 7 | AMGN |
Amgen Inc
|
499 | $180,697 | |
| 8 | AZN |
Astrazeneca PLC
|
828 | $157,005 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,636,771 | 41,882 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $10,146,704 | 41,510 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $8,821,036 | 42,624 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $7,934,863 | 42,794 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $6,882,304 | 45,056 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $8,302,613 | 50,064 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $9,016,044 | 62,343 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $11,649,521 | 71,884 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $10,568,975 | 72,311 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $12,078,755 | 76,356 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $12,351,268 | 78,801 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $12,607,028 | 80,944 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $13,477,134 | 81,423 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $13,002,795 | 83,889 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $13,355,446 | 75,604 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $12,360,634 | 75,665 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,260,529 | 74,703 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $13,280,907 | 74,936 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $3,970,192 | 23,208 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $3,898,448 | 24,139 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $4,152,601 | 25,207 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $4,539,675 | 27,622 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $4,105,729 | 26,088 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $3,730,039 | 25,054 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $4,000,501 | 28,447 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $3,422,099 | 26,097 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||